Global Non-opioid Analgesics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
According to our (Global Info Research) latest study, the global Non-opioid Analgesics market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-opioid Analgesics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Non-opioid Analgesics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Non-opioid Analgesics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Non-opioid Analgesics market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Non-opioid Analgesics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-opioid Analgesics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-opioid Analgesics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc. and Centrexion Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Non-opioid Analgesics market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-opioid Analgesics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-opioid Analgesics, with price, sales, revenue and global market share of Non-opioid Analgesics from 2017 to 2022.
Chapter 3, the Non-opioid Analgesics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-opioid Analgesics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and distribution channel, with sales market share and growth rate by type, distribution channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-opioid Analgesics market forecast, by regions, type and distribution channel, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-opioid Analgesics.
Chapter 14 and 15, to describe Non-opioid Analgesics sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Non-opioid Analgesics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Non-opioid Analgesics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Non-opioid Analgesics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Non-opioid Analgesics market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2017-2028
Global Non-opioid Analgesics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-opioid Analgesics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-opioid Analgesics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Viatris Inc. and Centrexion Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Non-opioid Analgesics market is split by Type and by Distribution Channel. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- NSAIDs
- Acetaminophen
- Local Anesthetics
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- AbbVie Inc
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Centrexion Therapeutics
- Cara Therapeutics
- Medropharm GmbH.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Non-opioid Analgesics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-opioid Analgesics, with price, sales, revenue and global market share of Non-opioid Analgesics from 2017 to 2022.
Chapter 3, the Non-opioid Analgesics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-opioid Analgesics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and distribution channel, with sales market share and growth rate by type, distribution channel, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-opioid Analgesics market forecast, by regions, type and distribution channel, with sales and revenue, from 2023 to 2028.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-opioid Analgesics.
Chapter 14 and 15, to describe Non-opioid Analgesics sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Non-opioid Analgesics Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-opioid Analgesics Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 NSAIDs
1.3.3 Acetaminophen
1.3.4 Local Anesthetics
1.4 Market Analysis by Distribution Channel
1.4.1 Overview: Global Non-opioid Analgesics Consumption Value by Distribution Channel: 2017 Versus 2021 Versus 2028
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Non-opioid Analgesics Market Size & Forecast
1.5.1 Global Non-opioid Analgesics Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Non-opioid Analgesics Sales Quantity (2017-2028)
1.5.3 Global Non-opioid Analgesics Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business
2.1.3 AbbVie Inc Non-opioid Analgesics Product and Services
2.1.4 AbbVie Inc Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 AbbVie Inc Recent Developments/Updates
2.2 Pfizer, Inc
2.2.1 Pfizer, Inc Details
2.2.2 Pfizer, Inc Major Business
2.2.3 Pfizer, Inc Non-opioid Analgesics Product and Services
2.2.4 Pfizer, Inc Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Pfizer, Inc Recent Developments/Updates
2.3 Teva Pharmaceutical Industries Ltd.
2.3.1 Teva Pharmaceutical Industries Ltd. Details
2.3.2 Teva Pharmaceutical Industries Ltd. Major Business
2.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product and Services
2.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.4 Viatris Inc.
2.4.1 Viatris Inc. Details
2.4.2 Viatris Inc. Major Business
2.4.3 Viatris Inc. Non-opioid Analgesics Product and Services
2.4.4 Viatris Inc. Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Viatris Inc. Recent Developments/Updates
2.5 Centrexion Therapeutics
2.5.1 Centrexion Therapeutics Details
2.5.2 Centrexion Therapeutics Major Business
2.5.3 Centrexion Therapeutics Non-opioid Analgesics Product and Services
2.5.4 Centrexion Therapeutics Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Centrexion Therapeutics Recent Developments/Updates
2.6 Cara Therapeutics
2.6.1 Cara Therapeutics Details
2.6.2 Cara Therapeutics Major Business
2.6.3 Cara Therapeutics Non-opioid Analgesics Product and Services
2.6.4 Cara Therapeutics Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Cara Therapeutics Recent Developments/Updates
2.7 Medropharm GmbH.
2.7.1 Medropharm GmbH. Details
2.7.2 Medropharm GmbH. Major Business
2.7.3 Medropharm GmbH. Non-opioid Analgesics Product and Services
2.7.4 Medropharm GmbH. Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Medropharm GmbH. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-OPIOID ANALGESICS BY MANUFACTURER
3.1 Global Non-opioid Analgesics Sales Quantity by Manufacturer (2017-2022)
3.2 Global Non-opioid Analgesics Revenue by Manufacturer (2017-2022)
3.3 Global Non-opioid Analgesics Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Non-opioid Analgesics by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Non-opioid Analgesics Manufacturer Market Share in 2021
3.4.2 Top 6 Non-opioid Analgesics Manufacturer Market Share in 2021
3.5 Non-opioid Analgesics Market: Overall Company Footprint Analysis
3.5.1 Non-opioid Analgesics Market: Region Footprint
3.5.2 Non-opioid Analgesics Market: Company Product Type Footprint
3.5.3 Non-opioid Analgesics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-opioid Analgesics Market Size by Region
4.1.1 Global Non-opioid Analgesics Sales Quantity by Region (2017-2028)
4.1.2 Global Non-opioid Analgesics Consumption Value by Region (2017-2028)
4.1.3 Global Non-opioid Analgesics Average Price by Region (2017-2028)
4.2 North America Non-opioid Analgesics Consumption Value (2017-2028)
4.3 Europe Non-opioid Analgesics Consumption Value (2017-2028)
4.4 Asia-Pacific Non-opioid Analgesics Consumption Value (2017-2028)
4.5 South America Non-opioid Analgesics Consumption Value (2017-2028)
4.6 Middle East and Africa Non-opioid Analgesics Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-opioid Analgesics Sales Quantity by Type (2017-2028)
5.2 Global Non-opioid Analgesics Consumption Value by Type (2017-2028)
5.3 Global Non-opioid Analgesics Average Price by Type (2017-2028)
6 MARKET SEGMENT BY DISTRIBUTION CHANNEL
6.1 Global Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
6.2 Global Non-opioid Analgesics Consumption Value by Distribution Channel (2017-2028)
6.3 Global Non-opioid Analgesics Average Price by Distribution Channel (2017-2028)
7 NORTH AMERICA
7.1 North America Non-opioid Analgesics Sales Quantity by Type (2017-2028)
7.2 North America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
7.3 North America Non-opioid Analgesics Market Size by Country
7.3.1 North America Non-opioid Analgesics Sales Quantity by Country (2017-2028)
7.3.2 North America Non-opioid Analgesics Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Non-opioid Analgesics Sales Quantity by Type (2017-2028)
8.2 Europe Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
8.3 Europe Non-opioid Analgesics Market Size by Country
8.3.1 Europe Non-opioid Analgesics Sales Quantity by Country (2017-2028)
8.3.2 Europe Non-opioid Analgesics Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-opioid Analgesics Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
9.3 Asia-Pacific Non-opioid Analgesics Market Size by Region
9.3.1 Asia-Pacific Non-opioid Analgesics Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Non-opioid Analgesics Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Non-opioid Analgesics Sales Quantity by Type (2017-2028)
10.2 South America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
10.3 South America Non-opioid Analgesics Market Size by Country
10.3.1 South America Non-opioid Analgesics Sales Quantity by Country (2017-2028)
10.3.2 South America Non-opioid Analgesics Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-opioid Analgesics Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
11.3 Middle East & Africa Non-opioid Analgesics Market Size by Country
11.3.1 Middle East & Africa Non-opioid Analgesics Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Non-opioid Analgesics Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Non-opioid Analgesics Market Drivers
12.2 Non-opioid Analgesics Market Restraints
12.3 Non-opioid Analgesics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-opioid Analgesics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-opioid Analgesics
13.3 Non-opioid Analgesics Production Process
13.4 Non-opioid Analgesics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-opioid Analgesics Typical Distributors
14.3 Non-opioid Analgesics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Non-opioid Analgesics Introduction
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Non-opioid Analgesics Consumption Value by Type: 2017 Versus 2021 Versus 2028
1.3.2 NSAIDs
1.3.3 Acetaminophen
1.3.4 Local Anesthetics
1.4 Market Analysis by Distribution Channel
1.4.1 Overview: Global Non-opioid Analgesics Consumption Value by Distribution Channel: 2017 Versus 2021 Versus 2028
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Non-opioid Analgesics Market Size & Forecast
1.5.1 Global Non-opioid Analgesics Consumption Value (2017 & 2021 & 2028)
1.5.2 Global Non-opioid Analgesics Sales Quantity (2017-2028)
1.5.3 Global Non-opioid Analgesics Average Price (2017-2028)
2 MANUFACTURERS PROFILES
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business
2.1.3 AbbVie Inc Non-opioid Analgesics Product and Services
2.1.4 AbbVie Inc Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 AbbVie Inc Recent Developments/Updates
2.2 Pfizer, Inc
2.2.1 Pfizer, Inc Details
2.2.2 Pfizer, Inc Major Business
2.2.3 Pfizer, Inc Non-opioid Analgesics Product and Services
2.2.4 Pfizer, Inc Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 Pfizer, Inc Recent Developments/Updates
2.3 Teva Pharmaceutical Industries Ltd.
2.3.1 Teva Pharmaceutical Industries Ltd. Details
2.3.2 Teva Pharmaceutical Industries Ltd. Major Business
2.3.3 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product and Services
2.3.4 Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
2.4 Viatris Inc.
2.4.1 Viatris Inc. Details
2.4.2 Viatris Inc. Major Business
2.4.3 Viatris Inc. Non-opioid Analgesics Product and Services
2.4.4 Viatris Inc. Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Viatris Inc. Recent Developments/Updates
2.5 Centrexion Therapeutics
2.5.1 Centrexion Therapeutics Details
2.5.2 Centrexion Therapeutics Major Business
2.5.3 Centrexion Therapeutics Non-opioid Analgesics Product and Services
2.5.4 Centrexion Therapeutics Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 Centrexion Therapeutics Recent Developments/Updates
2.6 Cara Therapeutics
2.6.1 Cara Therapeutics Details
2.6.2 Cara Therapeutics Major Business
2.6.3 Cara Therapeutics Non-opioid Analgesics Product and Services
2.6.4 Cara Therapeutics Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Cara Therapeutics Recent Developments/Updates
2.7 Medropharm GmbH.
2.7.1 Medropharm GmbH. Details
2.7.2 Medropharm GmbH. Major Business
2.7.3 Medropharm GmbH. Non-opioid Analgesics Product and Services
2.7.4 Medropharm GmbH. Non-opioid Analgesics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Medropharm GmbH. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NON-OPIOID ANALGESICS BY MANUFACTURER
3.1 Global Non-opioid Analgesics Sales Quantity by Manufacturer (2017-2022)
3.2 Global Non-opioid Analgesics Revenue by Manufacturer (2017-2022)
3.3 Global Non-opioid Analgesics Average Price by Manufacturer (2017-2022)
3.4 Market Share Analysis (2021)
3.4.1 Producer Shipments of Non-opioid Analgesics by Manufacturer Revenue ($MM) and Market Share (%): 2021
3.4.2 Top 3 Non-opioid Analgesics Manufacturer Market Share in 2021
3.4.2 Top 6 Non-opioid Analgesics Manufacturer Market Share in 2021
3.5 Non-opioid Analgesics Market: Overall Company Footprint Analysis
3.5.1 Non-opioid Analgesics Market: Region Footprint
3.5.2 Non-opioid Analgesics Market: Company Product Type Footprint
3.5.3 Non-opioid Analgesics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Non-opioid Analgesics Market Size by Region
4.1.1 Global Non-opioid Analgesics Sales Quantity by Region (2017-2028)
4.1.2 Global Non-opioid Analgesics Consumption Value by Region (2017-2028)
4.1.3 Global Non-opioid Analgesics Average Price by Region (2017-2028)
4.2 North America Non-opioid Analgesics Consumption Value (2017-2028)
4.3 Europe Non-opioid Analgesics Consumption Value (2017-2028)
4.4 Asia-Pacific Non-opioid Analgesics Consumption Value (2017-2028)
4.5 South America Non-opioid Analgesics Consumption Value (2017-2028)
4.6 Middle East and Africa Non-opioid Analgesics Consumption Value (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Non-opioid Analgesics Sales Quantity by Type (2017-2028)
5.2 Global Non-opioid Analgesics Consumption Value by Type (2017-2028)
5.3 Global Non-opioid Analgesics Average Price by Type (2017-2028)
6 MARKET SEGMENT BY DISTRIBUTION CHANNEL
6.1 Global Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
6.2 Global Non-opioid Analgesics Consumption Value by Distribution Channel (2017-2028)
6.3 Global Non-opioid Analgesics Average Price by Distribution Channel (2017-2028)
7 NORTH AMERICA
7.1 North America Non-opioid Analgesics Sales Quantity by Type (2017-2028)
7.2 North America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
7.3 North America Non-opioid Analgesics Market Size by Country
7.3.1 North America Non-opioid Analgesics Sales Quantity by Country (2017-2028)
7.3.2 North America Non-opioid Analgesics Consumption Value by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE
8.1 Europe Non-opioid Analgesics Sales Quantity by Type (2017-2028)
8.2 Europe Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
8.3 Europe Non-opioid Analgesics Market Size by Country
8.3.1 Europe Non-opioid Analgesics Sales Quantity by Country (2017-2028)
8.3.2 Europe Non-opioid Analgesics Consumption Value by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC
9.1 Asia-Pacific Non-opioid Analgesics Sales Quantity by Type (2017-2028)
9.2 Asia-Pacific Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
9.3 Asia-Pacific Non-opioid Analgesics Market Size by Region
9.3.1 Asia-Pacific Non-opioid Analgesics Sales Quantity by Region (2017-2028)
9.3.2 Asia-Pacific Non-opioid Analgesics Consumption Value by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA
10.1 South America Non-opioid Analgesics Sales Quantity by Type (2017-2028)
10.2 South America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
10.3 South America Non-opioid Analgesics Market Size by Country
10.3.1 South America Non-opioid Analgesics Sales Quantity by Country (2017-2028)
10.3.2 South America Non-opioid Analgesics Consumption Value by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Non-opioid Analgesics Sales Quantity by Type (2017-2028)
11.2 Middle East & Africa Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2028)
11.3 Middle East & Africa Non-opioid Analgesics Market Size by Country
11.3.1 Middle East & Africa Non-opioid Analgesics Sales Quantity by Country (2017-2028)
11.3.2 Middle East & Africa Non-opioid Analgesics Consumption Value by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 MARKET DYNAMICS
12.1 Non-opioid Analgesics Market Drivers
12.2 Non-opioid Analgesics Market Restraints
12.3 Non-opioid Analgesics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Non-opioid Analgesics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Non-opioid Analgesics
13.3 Non-opioid Analgesics Production Process
13.4 Non-opioid Analgesics Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Non-opioid Analgesics Typical Distributors
14.3 Non-opioid Analgesics Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-opioid Analgesics Consumption Value by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Inc Major Business
Table 5. AbbVie Inc Non-opioid Analgesics Product and Services
Table 6. AbbVie Inc Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. AbbVie Inc Recent Developments/Updates
Table 8. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer, Inc Major Business
Table 10. Pfizer, Inc Non-opioid Analgesics Product and Services
Table 11. Pfizer, Inc Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Pfizer, Inc Recent Developments/Updates
Table 13. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Ltd. Major Business
Table 15. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product and Services
Table 16. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 18. Viatris Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Inc. Major Business
Table 20. Viatris Inc. Non-opioid Analgesics Product and Services
Table 21. Viatris Inc. Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Viatris Inc. Recent Developments/Updates
Table 23. Centrexion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Centrexion Therapeutics Major Business
Table 25. Centrexion Therapeutics Non-opioid Analgesics Product and Services
Table 26. Centrexion Therapeutics Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Centrexion Therapeutics Recent Developments/Updates
Table 28. Cara Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. Cara Therapeutics Major Business
Table 30. Cara Therapeutics Non-opioid Analgesics Product and Services
Table 31. Cara Therapeutics Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. Cara Therapeutics Recent Developments/Updates
Table 33. Medropharm GmbH. Basic Information, Manufacturing Base and Competitors
Table 34. Medropharm GmbH. Major Business
Table 35. Medropharm GmbH. Non-opioid Analgesics Product and Services
Table 36. Medropharm GmbH. Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. Medropharm GmbH. Recent Developments/Updates
Table 38. Global Non-opioid Analgesics Sales Quantity by Manufacturer (2017-2022) & (K Units)
Table 39. Global Non-opioid Analgesics Revenue by Manufacturer (2017-2022) & (USD Million)
Table 40. Global Non-opioid Analgesics Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 41. Market Position of Manufacturers in Non-opioid Analgesics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 42. Head Office and Non-opioid Analgesics Production Site of Key Manufacturer
Table 43. Non-opioid Analgesics Market: Company Product Type Footprint
Table 44. Non-opioid Analgesics Market: Company Product Application Footprint
Table 45. Non-opioid Analgesics New Market Entrants and Barriers to Market Entry
Table 46. Non-opioid Analgesics Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Non-opioid Analgesics Sales Quantity by Region (2017-2022) & (K Units)
Table 48. Global Non-opioid Analgesics Sales Quantity by Region (2023-2028) & (K Units)
Table 49. Global Non-opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 50. Global Non-opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 51. Global Non-opioid Analgesics Average Price by Region (2017-2022) & (US$/Unit)
Table 52. Global Non-opioid Analgesics Average Price by Region (2023-2028) & (US$/Unit)
Table 53. Global Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 54. Global Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 55. Global Non-opioid Analgesics Consumption Value by Type (2017-2022) & (USD Million)
Table 56. Global Non-opioid Analgesics Consumption Value by Type (2023-2028) & (USD Million)
Table 57. Global Non-opioid Analgesics Average Price by Type (2017-2022) & (US$/Unit)
Table 58. Global Non-opioid Analgesics Average Price by Type (2023-2028) & (US$/Unit)
Table 59. Global Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 60. Global Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 61. Global Non-opioid Analgesics Consumption Value by Distribution Channel (2017-2022) & (USD Million)
Table 62. Global Non-opioid Analgesics Consumption Value by Distribution Channel (2023-2028) & (USD Million)
Table 63. Global Non-opioid Analgesics Average Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 64. Global Non-opioid Analgesics Average Price by Distribution Channel (2023-2028) & (US$/Unit)
Table 65. North America Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 66. North America Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 67. North America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 68. North America Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 69. North America Non-opioid Analgesics Sales Quantity by Country (2017-2022) & (K Units)
Table 70. North America Non-opioid Analgesics Sales Quantity by Country (2023-2028) & (K Units)
Table 71. North America Non-opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 72. North America Non-opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 73. Europe Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 74. Europe Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 75. Europe Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 76. Europe Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 77. Europe Non-opioid Analgesics Sales Quantity by Country (2017-2022) & (K Units)
Table 78. Europe Non-opioid Analgesics Sales Quantity by Country (2023-2028) & (K Units)
Table 79. Europe Non-opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 80. Europe Non-opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 82. Asia-Pacific Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 83. Asia-Pacific Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 84. Asia-Pacific Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 85. Asia-Pacific Non-opioid Analgesics Sales Quantity by Region (2017-2022) & (K Units)
Table 86. Asia-Pacific Non-opioid Analgesics Sales Quantity by Region (2023-2028) & (K Units)
Table 87. Asia-Pacific Non-opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 88. Asia-Pacific Non-opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 89. South America Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 90. South America Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 91. South America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 92. South America Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 93. South America Non-opioid Analgesics Sales Quantity by Country (2017-2022) & (K Units)
Table 94. South America Non-opioid Analgesics Sales Quantity by Country (2023-2028) & (K Units)
Table 95. South America Non-opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 96. South America Non-opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 98. Middle East & Africa Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 99. Middle East & Africa Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 100. Middle East & Africa Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 101. Middle East & Africa Non-opioid Analgesics Sales Quantity by Region (2017-2022) & (K Units)
Table 102. Middle East & Africa Non-opioid Analgesics Sales Quantity by Region (2023-2028) & (K Units)
Table 103. Middle East & Africa Non-opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 104. Middle East & Africa Non-opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 105. Non-opioid Analgesics Raw Material
Table 106. Key Manufacturers of Non-opioid Analgesics Raw Materials
Table 107. Non-opioid Analgesics Typical Distributors
Table 108. Non-opioid Analgesics Typical Customers
Table 1. Global Non-opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-opioid Analgesics Consumption Value by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Inc Major Business
Table 5. AbbVie Inc Non-opioid Analgesics Product and Services
Table 6. AbbVie Inc Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 7. AbbVie Inc Recent Developments/Updates
Table 8. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer, Inc Major Business
Table 10. Pfizer, Inc Non-opioid Analgesics Product and Services
Table 11. Pfizer, Inc Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 12. Pfizer, Inc Recent Developments/Updates
Table 13. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Industries Ltd. Major Business
Table 15. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Product and Services
Table 16. Teva Pharmaceutical Industries Ltd. Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 17. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 18. Viatris Inc. Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Inc. Major Business
Table 20. Viatris Inc. Non-opioid Analgesics Product and Services
Table 21. Viatris Inc. Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 22. Viatris Inc. Recent Developments/Updates
Table 23. Centrexion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Centrexion Therapeutics Major Business
Table 25. Centrexion Therapeutics Non-opioid Analgesics Product and Services
Table 26. Centrexion Therapeutics Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 27. Centrexion Therapeutics Recent Developments/Updates
Table 28. Cara Therapeutics Basic Information, Manufacturing Base and Competitors
Table 29. Cara Therapeutics Major Business
Table 30. Cara Therapeutics Non-opioid Analgesics Product and Services
Table 31. Cara Therapeutics Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 32. Cara Therapeutics Recent Developments/Updates
Table 33. Medropharm GmbH. Basic Information, Manufacturing Base and Competitors
Table 34. Medropharm GmbH. Major Business
Table 35. Medropharm GmbH. Non-opioid Analgesics Product and Services
Table 36. Medropharm GmbH. Non-opioid Analgesics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2017-2022)
Table 37. Medropharm GmbH. Recent Developments/Updates
Table 38. Global Non-opioid Analgesics Sales Quantity by Manufacturer (2017-2022) & (K Units)
Table 39. Global Non-opioid Analgesics Revenue by Manufacturer (2017-2022) & (USD Million)
Table 40. Global Non-opioid Analgesics Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 41. Market Position of Manufacturers in Non-opioid Analgesics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2021
Table 42. Head Office and Non-opioid Analgesics Production Site of Key Manufacturer
Table 43. Non-opioid Analgesics Market: Company Product Type Footprint
Table 44. Non-opioid Analgesics Market: Company Product Application Footprint
Table 45. Non-opioid Analgesics New Market Entrants and Barriers to Market Entry
Table 46. Non-opioid Analgesics Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Non-opioid Analgesics Sales Quantity by Region (2017-2022) & (K Units)
Table 48. Global Non-opioid Analgesics Sales Quantity by Region (2023-2028) & (K Units)
Table 49. Global Non-opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 50. Global Non-opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 51. Global Non-opioid Analgesics Average Price by Region (2017-2022) & (US$/Unit)
Table 52. Global Non-opioid Analgesics Average Price by Region (2023-2028) & (US$/Unit)
Table 53. Global Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 54. Global Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 55. Global Non-opioid Analgesics Consumption Value by Type (2017-2022) & (USD Million)
Table 56. Global Non-opioid Analgesics Consumption Value by Type (2023-2028) & (USD Million)
Table 57. Global Non-opioid Analgesics Average Price by Type (2017-2022) & (US$/Unit)
Table 58. Global Non-opioid Analgesics Average Price by Type (2023-2028) & (US$/Unit)
Table 59. Global Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 60. Global Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 61. Global Non-opioid Analgesics Consumption Value by Distribution Channel (2017-2022) & (USD Million)
Table 62. Global Non-opioid Analgesics Consumption Value by Distribution Channel (2023-2028) & (USD Million)
Table 63. Global Non-opioid Analgesics Average Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 64. Global Non-opioid Analgesics Average Price by Distribution Channel (2023-2028) & (US$/Unit)
Table 65. North America Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 66. North America Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 67. North America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 68. North America Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 69. North America Non-opioid Analgesics Sales Quantity by Country (2017-2022) & (K Units)
Table 70. North America Non-opioid Analgesics Sales Quantity by Country (2023-2028) & (K Units)
Table 71. North America Non-opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 72. North America Non-opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 73. Europe Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 74. Europe Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 75. Europe Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 76. Europe Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 77. Europe Non-opioid Analgesics Sales Quantity by Country (2017-2022) & (K Units)
Table 78. Europe Non-opioid Analgesics Sales Quantity by Country (2023-2028) & (K Units)
Table 79. Europe Non-opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 80. Europe Non-opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 82. Asia-Pacific Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 83. Asia-Pacific Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 84. Asia-Pacific Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 85. Asia-Pacific Non-opioid Analgesics Sales Quantity by Region (2017-2022) & (K Units)
Table 86. Asia-Pacific Non-opioid Analgesics Sales Quantity by Region (2023-2028) & (K Units)
Table 87. Asia-Pacific Non-opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 88. Asia-Pacific Non-opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 89. South America Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 90. South America Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 91. South America Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 92. South America Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 93. South America Non-opioid Analgesics Sales Quantity by Country (2017-2022) & (K Units)
Table 94. South America Non-opioid Analgesics Sales Quantity by Country (2023-2028) & (K Units)
Table 95. South America Non-opioid Analgesics Consumption Value by Country (2017-2022) & (USD Million)
Table 96. South America Non-opioid Analgesics Consumption Value by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Non-opioid Analgesics Sales Quantity by Type (2017-2022) & (K Units)
Table 98. Middle East & Africa Non-opioid Analgesics Sales Quantity by Type (2023-2028) & (K Units)
Table 99. Middle East & Africa Non-opioid Analgesics Sales Quantity by Distribution Channel (2017-2022) & (K Units)
Table 100. Middle East & Africa Non-opioid Analgesics Sales Quantity by Distribution Channel (2023-2028) & (K Units)
Table 101. Middle East & Africa Non-opioid Analgesics Sales Quantity by Region (2017-2022) & (K Units)
Table 102. Middle East & Africa Non-opioid Analgesics Sales Quantity by Region (2023-2028) & (K Units)
Table 103. Middle East & Africa Non-opioid Analgesics Consumption Value by Region (2017-2022) & (USD Million)
Table 104. Middle East & Africa Non-opioid Analgesics Consumption Value by Region (2023-2028) & (USD Million)
Table 105. Non-opioid Analgesics Raw Material
Table 106. Key Manufacturers of Non-opioid Analgesics Raw Materials
Table 107. Non-opioid Analgesics Typical Distributors
Table 108. Non-opioid Analgesics Typical Customers
LIST OF FIGURES
s
Figure 1. Non-opioid Analgesics Picture
Figure 2. Global Non-opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Non-opioid Analgesics Consumption Value Market Share by Type in 2021
Figure 4. NSAIDs Examples
Figure 5. Acetaminophen Examples
Figure 6. Local Anesthetics Examples
Figure 7. Global Non-opioid Analgesics Consumption Value by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Figure 8. Global Non-opioid Analgesics Consumption Value Market Share by Distribution Channel in 2021
Figure 9. Hospital Pharmacies Examples
Figure 10. Retail Pharmacies Examples
Figure 11. Online Pharmacies Examples
Figure 12. Global Non-opioid Analgesics Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 13. Global Non-opioid Analgesics Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 14. Global Non-opioid Analgesics Sales Quantity (2017-2028) & (K Units)
Figure 15. Global Non-opioid Analgesics Average Price (2017-2028) & (US$/Unit)
Figure 16. Global Non-opioid Analgesics Sales Quantity Market Share by Manufacturer in 2021
Figure 17. Global Non-opioid Analgesics Consumption Value Market Share by Manufacturer in 2021
Figure 18. Producer Shipments of Non-opioid Analgesics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Non-opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Top 6 Non-opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 21. Global Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 22. Global Non-opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 23. North America Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 24. Europe Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 25. Asia-Pacific Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 26. South America Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 27. Middle East & Africa Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 28. Global Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 29. Global Non-opioid Analgesics Consumption Value Market Share by Type (2017-2028)
Figure 30. Global Non-opioid Analgesics Average Price by Type (2017-2028) & (US$/Unit)
Figure 31. Global Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 32. Global Non-opioid Analgesics Consumption Value Market Share by Distribution Channel (2017-2028)
Figure 33. Global Non-opioid Analgesics Average Price by Distribution Channel (2017-2028) & (US$/Unit)
Figure 34. North America Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 35. North America Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 36. North America Non-opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 37. North America Non-opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 38. United States Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Canada Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Mexico Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 41. Europe Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 42. Europe Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 43. Europe Non-opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 44. Europe Non-opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 45. Germany Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. France Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. United Kingdom Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Russia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Italy Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 50. Asia-Pacific Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 51. Asia-Pacific Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 52. Asia-Pacific Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Non-opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 54. China Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. Korea Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 61. South America Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 62. South America Non-opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 63. South America Non-opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 64. Brazil Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East & Africa Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 67. Middle East & Africa Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 68. Middle East & Africa Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 69. Middle East & Africa Non-opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 70. Turkey Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Egypt Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Africa Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 74. Non-opioid Analgesics Market Drivers
Figure 75. Non-opioid Analgesics Market Restraints
Figure 76. Non-opioid Analgesics Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Non-opioid Analgesics in 2021
Figure 79. Manufacturing Process Analysis of Non-opioid Analgesics
Figure 80. Non-opioid Analgesics Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
s
Figure 1. Non-opioid Analgesics Picture
Figure 2. Global Non-opioid Analgesics Consumption Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 3. Global Non-opioid Analgesics Consumption Value Market Share by Type in 2021
Figure 4. NSAIDs Examples
Figure 5. Acetaminophen Examples
Figure 6. Local Anesthetics Examples
Figure 7. Global Non-opioid Analgesics Consumption Value by Distribution Channel, (USD Million), 2017 & 2021 & 2028
Figure 8. Global Non-opioid Analgesics Consumption Value Market Share by Distribution Channel in 2021
Figure 9. Hospital Pharmacies Examples
Figure 10. Retail Pharmacies Examples
Figure 11. Online Pharmacies Examples
Figure 12. Global Non-opioid Analgesics Consumption Value, (USD Million): 2017 & 2021 & 2028
Figure 13. Global Non-opioid Analgesics Consumption Value and Forecast (2017-2028) & (USD Million)
Figure 14. Global Non-opioid Analgesics Sales Quantity (2017-2028) & (K Units)
Figure 15. Global Non-opioid Analgesics Average Price (2017-2028) & (US$/Unit)
Figure 16. Global Non-opioid Analgesics Sales Quantity Market Share by Manufacturer in 2021
Figure 17. Global Non-opioid Analgesics Consumption Value Market Share by Manufacturer in 2021
Figure 18. Producer Shipments of Non-opioid Analgesics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Non-opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 20. Top 6 Non-opioid Analgesics Manufacturer (Consumption Value) Market Share in 2021
Figure 21. Global Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 22. Global Non-opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 23. North America Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 24. Europe Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 25. Asia-Pacific Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 26. South America Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 27. Middle East & Africa Non-opioid Analgesics Consumption Value (2017-2028) & (USD Million)
Figure 28. Global Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 29. Global Non-opioid Analgesics Consumption Value Market Share by Type (2017-2028)
Figure 30. Global Non-opioid Analgesics Average Price by Type (2017-2028) & (US$/Unit)
Figure 31. Global Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 32. Global Non-opioid Analgesics Consumption Value Market Share by Distribution Channel (2017-2028)
Figure 33. Global Non-opioid Analgesics Average Price by Distribution Channel (2017-2028) & (US$/Unit)
Figure 34. North America Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 35. North America Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 36. North America Non-opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 37. North America Non-opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 38. United States Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 39. Canada Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 40. Mexico Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 41. Europe Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 42. Europe Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 43. Europe Non-opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 44. Europe Non-opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 45. Germany Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 46. France Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 47. United Kingdom Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 48. Russia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 49. Italy Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 50. Asia-Pacific Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 51. Asia-Pacific Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 52. Asia-Pacific Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Non-opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 54. China Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 56. Korea Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 61. South America Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 62. South America Non-opioid Analgesics Sales Quantity Market Share by Country (2017-2028)
Figure 63. South America Non-opioid Analgesics Consumption Value Market Share by Country (2017-2028)
Figure 64. Brazil Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East & Africa Non-opioid Analgesics Sales Quantity Market Share by Type (2017-2028)
Figure 67. Middle East & Africa Non-opioid Analgesics Sales Quantity Market Share by Distribution Channel (2017-2028)
Figure 68. Middle East & Africa Non-opioid Analgesics Sales Quantity Market Share by Region (2017-2028)
Figure 69. Middle East & Africa Non-opioid Analgesics Consumption Value Market Share by Region (2017-2028)
Figure 70. Turkey Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 71. Egypt Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Africa Non-opioid Analgesics Consumption Value and Growth Rate (2017-2028) & (USD Million)
Figure 74. Non-opioid Analgesics Market Drivers
Figure 75. Non-opioid Analgesics Market Restraints
Figure 76. Non-opioid Analgesics Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Non-opioid Analgesics in 2021
Figure 79. Manufacturing Process Analysis of Non-opioid Analgesics
Figure 80. Non-opioid Analgesics Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
